Skip the primary navigation if you do not want to read it as the next section.
Skip the main content if you do not want to read it as the next section.
GPs barred from prescribing epilepsy drug Retigabine
GPs are being barred from prescribing epilepsy drug Retigabine despite NICE’s approval.
Epilepsy drug Retigabine is one of the drugs 'blacklisted' by some Primary Care Trusts (PCTs) according to an investigation by GP Magazine.
It revealed that one in four PCTs have barred GPs from prescribing certain drugs, including Retigabine, because they are deemed too expensive or not effective enough, even though the National Institute of Health and Clinical Excellence (NICE) has recommended their use.
Epilepsy Society would like to hear from you if you have experienced problems with your prescription for Retigabine. Please contact Epilepsy Society and tell us of your experience.